Annual SG&A
$192.69 M
+$29.39 M+18.00%
31 December 2023
Summary:
Harmony Biosciences Holdings annual selling, general & administrative expenses is currently $192.69 million, with the most recent change of +$29.39 million (+18.00%) on 31 December 2023. During the last 3 years, it has risen by +$60.67 million (+45.95%). HRMY annual SG&A is now at all-time high.HRMY Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$56.16 M
+$432.00 K+0.78%
30 September 2024
Summary:
Harmony Biosciences Holdings quarterly selling, general & administrative expenses is currently $56.16 million, with the most recent change of +$432.00 thousand (+0.78%) on 30 September 2024. Over the past year, it has increased by +$1.41 million (+2.57%). HRMY quarterly SG&A is now at all-time high.HRMY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$388.83 M
+$122.63 M+23.98%
30 September 2024
Summary:
Harmony Biosciences Holdings TTM selling, general & administrative expenses is currently -$388.83 million, with the most recent change of +$122.63 million (+23.98%) on 30 September 2024. Over the past year, it has dropped by -$581.52 million (-301.79%). HRMY TTM SG&A is now at all-time high.HRMY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRMY Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +2.6% | -301.8% |
| 3 y3 years | +46.0% | +50.5% | -394.5% |
| 5 y5 years | +138.7% | +82.1% | -581.7% |
HRMY Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.0% | at high | +58.4% | at high | +79.3% |
| 5 y | 5 years | at high | +138.7% | at high | +179.8% | at high | +80.0% |
| alltime | all time | at high | +562.9% | at high | +453.2% | at high | +80.0% |
Harmony Biosciences Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $56.16 M(+0.8%) | $219.56 M(+4.9%) |
| June 2024 | - | $55.73 M(+5.3%) | $209.36 M(+4.2%) |
| Mar 2024 | - | $52.91 M(-3.4%) | $200.97 M(+4.3%) |
| Dec 2023 | $192.69 M(+18.0%) | $54.76 M(+19.1%) | $192.69 M(+6.1%) |
| Sept 2023 | - | $45.96 M(-2.9%) | $181.65 M(+2.3%) |
| June 2023 | - | $47.34 M(+6.1%) | $177.49 M(+2.9%) |
| Mar 2023 | - | $44.63 M(+2.1%) | $172.47 M(+5.6%) |
| Dec 2022 | $163.30 M(+23.7%) | $43.72 M(+4.6%) | $163.30 M(+4.1%) |
| Sept 2022 | - | $41.80 M(-1.2%) | $156.90 M(+5.7%) |
| June 2022 | - | $42.32 M(+19.3%) | $148.44 M(+8.0%) |
| Mar 2022 | - | $35.46 M(-5.0%) | $137.44 M(+4.1%) |
| Dec 2021 | $132.03 M | $37.31 M(+11.9%) | $132.03 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $33.34 M(+6.4%) | $125.71 M(+8.9%) |
| June 2021 | - | $31.32 M(+4.2%) | $115.48 M(+10.8%) |
| Mar 2021 | - | $30.05 M(-3.0%) | $104.23 M(+7.8%) |
| Dec 2020 | $95.57 M(+18.4%) | $30.99 M(+34.1%) | $96.72 M(+0.2%) |
| Sept 2020 | - | $23.11 M(+15.1%) | $96.56 M(-2.4%) |
| June 2020 | - | $20.07 M(-11.0%) | $98.92 M(+6.2%) |
| Mar 2020 | - | $22.54 M(-26.9%) | $93.12 M(+15.3%) |
| Dec 2019 | $80.73 M(+177.7%) | $30.84 M(+21.1%) | $80.73 M(+61.8%) |
| Sept 2019 | - | $25.47 M(+78.5%) | $49.89 M(+104.3%) |
| June 2019 | - | $14.27 M(+40.5%) | $24.42 M(+140.5%) |
| Mar 2019 | - | $10.15 M | $10.15 M |
| Dec 2018 | $29.07 M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly SG&A year-on-year change?
- What is Harmony Biosciences Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM SG&A year-on-year change?
What is Harmony Biosciences Holdings annual selling, general & administrative expenses?
The current annual SG&A of HRMY is $192.69 M
What is the all time high annual SG&A for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual selling, general & administrative expenses is $192.69 M
What is Harmony Biosciences Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of HRMY is $56.16 M
What is the all time high quarterly SG&A for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly selling, general & administrative expenses is $56.16 M
What is Harmony Biosciences Holdings quarterly SG&A year-on-year change?
Over the past year, HRMY quarterly selling, general & administrative expenses has changed by +$1.41 M (+2.57%)
What is Harmony Biosciences Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of HRMY is -$388.83 M
What is the all time high TTM SG&A for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM selling, general & administrative expenses is $219.56 M
What is Harmony Biosciences Holdings TTM SG&A year-on-year change?
Over the past year, HRMY TTM selling, general & administrative expenses has changed by -$581.52 M (-301.79%)